Join the club for FREE to access the whole archive and other member benefits.

Should WHO use a new framework for the diagnosis and treatment of age-related diseases?

LEAF summarises and exchange of thoughts between leading aging researchers

08-May-2020

Key points from article :

Classification and severity staging of age-related diseases is limited in effectiveness.

Next revision of the ICD is anticipated to be in 2028 or later.

Researchers created a position statement to comprehensively classify the severity of age-related diseases.

Were guided by Dr. Stuart Calimport and Dr. João Pedro de Magalhães.

Dr. Alexander Zhavronkov suggests it overestimates our understanding of aging in the context of classifying age-related diseases.

Still yet to be a consensus on which biomarkers of aging are optimal for measuring senescence.

Dr. Stuart Calimport counters that staging levels are already part of ICD, e.g. photo-aging of the skin.

Classification could distinguish between early life senescence and the harmful decline aging causes later in life.

Mentioned in this article:

Click on resource name for more details.

Alex Zhavoronkov

CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation

João Pedro de Magalhães

Professor of Molecular Biogerontology at University of Birmingham Institute of Inflammation and Ageing, consultant, futurist, speaker

Stuart Calimport

Honorary Fellow at University of Liverpool

World Health Organization (WHO)

Specialized agency of the United Nations responsible for international public health

Topics mentioned on this page:
Ageing Research